EU_Cardio_Contents_Layout 1 04/02/2010 11:07 Page 6
Contents
Heart Failure
Beyond the Apnoea–Hypopnoea Index – Prognostic Value of Other Elements of
Polysomnography to Describe Sleep-disordered Breathing in Heart Failure 53
Philip B Adamson
The Heart Failure Institute, Oklahoma Heart Hospital, Oklahoma Foundation for Cardiovascular Research, and
Department of Physiology, University of Oklahoma Health Sciences Center
Atrial Fibrillation
Anticoagulant Therapy in Atrial Fibrillation – Time for a Change? 57
Raffaele De Caterina and Giulia Renda
Institute of Cardiology and Centre of Excellence on Ageing, ‘G d’Annunzio’ University, Chieti
Atrial Fibrillation and Renin–Angiotensin System Blockade in Hypertension 63
Tonje A Aksnes,
1
Markus P Schneider,
2
Sverre E Kjeldsen,
1,3
Kristian Wachtell
4
and Roland E Schmieder
2
1. Department of Cardiology, Oslo University Hospital; 2. Department of Nephrology and Hypertension,
University of Erlangen-Nuremberg; 3. Division of Cardiovascular Medicine, University of Michigan, Ann Arbor;
4. Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen
Interventional Cardiology
A Comparison of Drug-eluting Stents for Percutaneous Coronary Intervention –
Background, Rationale and Design of the COMPARE Trial 69
Pieter C Smits
Department of Cardiology, Thorax Centre, Erasmus Medical Centre, Rotterdam
Clinical Application of a Novel Self-expanding Coronary Stent in
Acute Myocardial Infarction 71
Christian Spaulding
Professor of Cardiology, Paris Descartes University and INSERM U 970, and
Director, Catheterisation Laboratory, Cochin Hospital, Paris
Treatment of In-stent Restenosis – Past, Present and Future 74
Fernando Alfonso
Interventional Cardiologist, Cardiovascular Institute, San Carlos University Hospital, Madrid
Drug-eluting Balloons – The Next Sustainable Device Platform in
Cardiovascular Disease? 79
Rick Geoffrion
Vice President, Global Marketing and Strategic Planning, Invatec, Frauenfeld
Aortic Stenosis
New Trends and Developments in Patients with Severe Aortic Stenosis –
Towards Optimal Treatment? 81
Martijn WA van Geldorp, Johanna JM Takkenberg, Ad JJC Bogers and A Pieter Kappetein
Department of Cardiothoracic Surgery, Erasmus University Medical Centre Rotterdam
Atherosclerosis
Atherosclerosis – The Future Challenge for Europe’s Health Economies 86
Andrew Carson
Associate Dean, School of Post-graduate General Practice, NHS West Midlands, and
General Practitioner, Bellevue Medical Centre, Birmingham
6 EUROPEAN CARDIOLOGY
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92